Gonorrhea cases up 17% in Europe

  • ECDC
  • ECDC

  • de Liz Scherer
  • Clinical Essentials
El acceso al contenido completo es sólo para profesionales sanitarios registrados. El acceso al contenido completo es sólo para profesionales sanitarios registrados.

Takeaway

  • European Centre for Disease Prevention and Control (ECDC) reports a 17% rise in gonorrhea cases from 2016 to 2017 across reporting European Union/European Economic Area (EU/EEA) countries.
  • Gonorrhea is now the second most notified sexually transmitted infection (STI) in the EU/EEA after chlamydia.

Why this matters

  • Consider pretravel consultations in high-risk patients (especially men who have sex with men [MSM], HIV-positive, and women of reproductive age).
  • Encourage condom use, increased testing uptake/frequency.

Key points

  • Report is based on gonorrhea case data collected by the European Sexually Transmitted Infection Surveillance Network, 2017.
  • 89,239 confirmed cases were reported by 27 EU/EEA member states in 2017, representing a 17% increase over 2016.
  • Crude notification rate: 22.2/100,000 population (22% increase vs 2016).
  • 17 countries accounted for 77% of cases, with highest rates (>25/100,000 population): UK (75/100,000), Ireland (47/100,000), Denmark (33/100,000), Iceland (29/100,000), Norway (27/100,000), Sweden (25/100,000).
  • MSM accounted, heterosexuals, unknown accounted for 47%, 45%, 9% of cases, respectively.
  • Largest increases since 2008 noted among ages 25-34 (2.7-fold), 35-44 (2.6-fold), ≥45 (2.6-fold) years.
  • 5-24 years accounted for 36% of 2017 cases.
  • Among cases with known HIV status, 14% were HIV-positive; 22% of known MSM HIV status cases were HIV-positive.